NeuPath Health Inc (V:NPTH) — Market Cap & Net Worth
Market Cap & Net Worth: NeuPath Health Inc (NPTH)
NeuPath Health Inc (V:NPTH) has a market capitalization of $25.60 Million (CA$35.39 Million) as of June 16, 2026. Listed on the V stock exchange, this Canada-based company holds position #24326 globally and #926 in its home market, demonstrating a 6.78% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NeuPath Health Inc's stock price CA$0.63 by its total outstanding shares 56180787 (56.18 Million). Review NPTH current and long-term liabilities to assess the company's total debt and financial obligations.
NeuPath Health Inc Market Cap History: 2019 to 2026
NeuPath Health Inc's market capitalization history from 2019 to 2026. Data shows change from $36.58 Million to $25.60 Million (-6.84% CAGR).
NeuPath Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NeuPath Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.23x
NeuPath Health Inc's market cap is 0.23 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $36.58 Million | $49.64 Million | -$5.31 Million | 0.74x | N/A |
| 2020 | $31.29 Million | $47.64 Million | -$5.06 Million | 0.66x | N/A |
| 2021 | $20.32 Million | $60.86 Million | -$3.23 Million | 0.33x | N/A |
| 2022 | $7.32 Million | $62.65 Million | -$4.17 Million | 0.12x | N/A |
| 2023 | $7.52 Million | $66.10 Million | -$107.00K | 0.11x | N/A |
| 2024 | $8.53 Million | $72.81 Million | -$728.00K | 0.12x | N/A |
| 2025 | $20.32 Million | $87.19 Million | -$717.00K | 0.23x | N/A |
Competitor Companies of NPTH by Market Capitalization
Companies near NeuPath Health Inc in the global market cap rankings as of June 16, 2026.
Key companies related to NeuPath Health Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #328 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #992 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1078 globally with a market cap of $24.81 Billion USD ( €21.22 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1325 globally with a market cap of $19.48 Billion USD ( RM77.58 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #328 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $387.18 |
| #992 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1078 | Fresenius SE & Co. KGaA | XETRA:FRE | $24.81 Billion | €37.67 |
| #1325 | IHH Healthcare Bhd | KLSE:5225 | $19.48 Billion | RM8.78 |
NeuPath Health Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, NeuPath Health Inc's market cap moved from $36.58 Million to $ 25.60 Million, with a yearly change of -6.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$25.60 Million | +26.00% |
| 2025 | CA$20.32 Million | +138.10% |
| 2024 | CA$8.53 Million | +13.51% |
| 2023 | CA$7.52 Million | +2.78% |
| 2022 | CA$7.32 Million | -64.00% |
| 2021 | CA$20.32 Million | -35.06% |
| 2020 | CA$31.29 Million | -14.44% |
| 2019 | CA$36.58 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 15th, 2026 the market cap of NeuPath Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.60 Million USD |
| MoneyControl | $25.60 Million USD |
| MarketWatch | $25.60 Million USD |
| marketcap.company | $25.60 Million USD |
| Reuters | $25.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NeuPath Health Inc
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and di… Read more